These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3918313)

  • 21. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of functional T cell recognition sites on I-E molecules.
    Needleman BW; Pierres M; Devaux CA; Dwyer PN; Finnegan A; Sachs DH; Hodes RJ
    J Immunol; 1984 Aug; 133(2):589-96. PubMed ID: 6203968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of MHC class II: a role for dimer of dimers.
    Schafer PH; Pierce SK; Jardetzky TS
    Semin Immunol; 1995 Dec; 7(6):389-98. PubMed ID: 8775464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The recognition of MHC molecules by gamma delta T cells.
    Schild H; Chien YH
    Behring Inst Mitt; 1994 Jul; (94):113-23. PubMed ID: 7998905
    [No Abstract]   [Full Text] [Related]  

  • 26. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ia molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation.
    Heber-Katz E; Hansburg D; Schwartz RH
    J Mol Cell Immunol; 1983; 1(1):3-18. PubMed ID: 6101061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
    Yagi J; Uchiyama T; Janeway CA
    J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms involved in the Ir-gene control of T suppressor cell response to lactate dehydrogenase B.
    Baxevanis CN; Ikezawa Z; Klein J; Nagy ZA
    J Mol Cell Immunol; 1984; 1(4):201-10. PubMed ID: 6242858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct observation of ligand recognition by T cells.
    Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
    Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fate of intercellular MHC-peptide-T-cell receptor complexes during T-cell activation.
    Clark BR
    J Mol Recognit; 1995; 8(1-2):63-6. PubMed ID: 7598954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology. The ins and outs of antigen processing and presentation.
    Germain RN
    Nature; 1986 Aug 21-27; 322(6081):687-9. PubMed ID: 3489186
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
    Berzofsky JA
    J Clin Invest; 1988 Dec; 82(6):1811-7. PubMed ID: 2974044
    [No Abstract]   [Full Text] [Related]  

  • 36. Indirect presentation of allogeneic major histocompatibility complex antigens by syngeneic macrophages.
    Dutta D; Meeusen E; Boyle W
    Transplant Proc; 1985 Apr; 17(2):1661-3. PubMed ID: 3157249
    [No Abstract]   [Full Text] [Related]  

  • 37. Problems in the physiology of class I and class II MHC molecules, and of CD45.
    Fisher AG; Goff LK; Lightstone L; Marvel J; Mitchison NA; Poirier G; Stauss H; Zamoyska R
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():667-74. PubMed ID: 2534841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility antigen expression in rejection: cause or consequence?
    Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):602-4. PubMed ID: 2495623
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of MHC product induction may contribute to the immunosuppressive action of ciclosporin.
    Halloran PF; Wadgymar A; Autenried P
    Prog Allergy; 1986; 38():258-68. PubMed ID: 2425369
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular events in the processing of avidin by antigen-presenting cells (APC). III. Activation of T-lymphocyte lines and H-2 restriction are mediated by processed avidin associated with I-region gene products.
    Friedman A; Zerubavel R; Gitler C; Cohen IR
    Immunogenetics; 1983; 18(3):291-302. PubMed ID: 6413394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.